December 22, 2020
In this presentation given at Ending Age-Related Diseases 2020, Dr. Sajad Zalzala of AgelessRx discusses PEARL, a human trial of rapamycin that uses the participation of ordinary people in order to get a large sample size without the expense of a traditional clinical trial. He discusses the use and effectiveness of rapamycin as an aging...